The increase of IL-10+ Th17, together with the aforementioned global CD4+ altered frequency, taking into account the singular infectious susceptibility of AML patients and the physiological protective role of Th17 cells, seem to strengthen the hypothesis of a reduced immune response in these patients. This evidence concerns the gene CD4 and acute myeloid leukemia.